Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 47, Issue 11 (Nov 2009)

Issues

Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism

Eloísa Urrechaga / Luís Borque
  • Department of Pharmacology and Physiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jesús F. Escanero
  • Department of Pharmacology and Physiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2009-10-12 | DOI: https://doi.org/10.1515/CCLM.2009.301

Abstract

Background: New erythrocyte parameters are reported by the Sysmex XE 5000 analyzer. This instrument measures the hemoglobin (Hb) content of individual red cells, calculates the percentage of hypochromic red cells (%Hypo He) and the percentage of hyperchromic red cells (%Hyper He) and quantifies the proportion of marginally sized erythrocytes (%Micro R and %Macro R). The goals of the study were to establish the reference range for erythrocyte extended parameters, their value in different types of anemia and to investigate their reliability in the study of disorders of iron metabolism.

Materials: Three hundred and ninety samples were analyzed. The Kolmogorov-Smirnoff test, independent samples t-test and Pearson correlation were calculated; receiver operating characteristic (ROC) curve analysis was used to determine their diagnostic performance.

Results: The values of the four parameters studied were normally distributed and statistically different (p<0.0001) in the different groups of patients; the only exception was %Hypo He in cases of iron deficiency and thalassemia (p=0.3758). Results of ROC curve analysis for %Hypo He in the diagnosis of restricted erythropoiesis reticulocyte Hb content (reticulocyte hemoglobin content, Ret He <29 pg) were: area under the curve 0.963; cut-off 1.8%; sensitivity 98.3%; specificity 91.1%.

Conclusions: The new parameters appear to be sensitive for detecting small changes in the number of red cells with inadequate hemoglobinization and volume.

Clin Chem Lab Med 2009;47:1411–6.

Keywords: hypochromia; mature erythrocyte; microcytosis; restricted erythropoiesis

About the article

Corresponding author: Dr. Eloísa Urrechaga, Hematology Laboratory, Hospital Galdakao, Usansolo, 48960 Galdakao, Vizcaya, Spain Phone: +34 94 400 7102, Fax: +34 94 400 7128,


Received: 2009-04-20

Accepted: 2009-07-13

Published Online: 2009-10-12

Published in Print: 2009-11-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2009.301.

Export Citation

©2009 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
M. Buttarello, A. Rauli, and G. Mezzapelle
International Journal of Laboratory Hematology, 2017
[2]
Margreet Schoorl, Marianne Schoorl, Jo Linssen, Miriam Martinez Villanueva, José A Velasco NoGuera, Pedro Hernandez Martinez, and Piet C.M. Bartels
American Journal of Clinical Pathology, 2012, Volume 138, Number 2, Page 300
[3]
Angeli Ambayya, Anselm Ting Su, Nadila Haryani Osman, Nik Rosnita Nik-Samsudin, Khadijah Khalid, Kian Meng Chang, Jameela Sathar, Jay Suriar Rajasuriar, Subramanian Yegappan, and Aditya Bhushan Pant
PLoS ONE, 2014, Volume 9, Number 3, Page e91968
[4]
E. Urrechaga, O. Boveda, F. J. Aguayo, P. de la Hera, R. I. Muñoz, I. Gallardo, and J. F. Escanero
International Journal of Laboratory Hematology, 2016, Volume 38, Number 4, Page 360
[5]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
Journal of Clinical Laboratory Analysis, 2016, Volume 30, Number 5, Page 623
[6]
David H. Hwang, David M. Dorfman, Dick G. Hwang, Patricia Senna, and Olga Pozdnyakova
American Journal of Clinical Pathology, 2016, Volume 145, Number 3, Page 379
[7]
Carol J. Briggs, Joachim Linssen, Ian Longair, and Samuel J. Machin
American Journal of Clinical Pathology, 2011, Volume 136, Number 2, Page 309
[8]
Ana Beatriz Barbosa Torino, Maria de Fátima Pererira Gilberti, Edvilson da Costa, Gisélia Aparecida Freire de Lima, and Helena Zerlotti Wolf Grotto
Revista Brasileira de Hematologia e Hemoterapia, 2015, Volume 37, Number 2, Page 77
[9]
Sigismond Lasocki, Nicolas Chudeau, Thibaut Papet, Deborah Tartiere, Antoine Roquilly, Laurence Carlier, Olivier Mimoz, Philippe Seguin, Yannick Malledant, Karim Asehnoune, and Jean François Hamel
Critical Care, 2014, Volume 18, Number 5
[10]
Ana Beatriz Barbosa Torino, Maria de Fátima Pererira Gilberti, Edvilson da Costa, Gisélia Aparecida Freire de Lima, and Helena Zerlotti Wolf Grotto
Revista Brasileira de Hematologia e Hemoterapia, 2014, Volume 36, Number 6, Page 424
[11]
E. Urrechaga, J. J. M. L. Hoffmann, S. Izquierdo, and J. F. Escanero
International Journal of Laboratory Hematology, 2015, Volume 37, Number 3, Page 334
[12]
K. Danielson, S. Beshara, A. R. Qureshi, O. Heimburger, B. Lindholm, M. Hansson, B. Hylander, G. Germanis, P. Stenvinkel, and P. Barany
Clinical Kidney Journal, 2014, Volume 7, Number 3, Page 275
[13]
D. Wayne Thomas, Rod F. Hinchliffe, Carol Briggs, Iain C. Macdougall, Tim Littlewood, and Ivor Cavill
British Journal of Haematology, 2013, Volume 161, Number 5, Page 639
[14]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
BioMed Research International, 2013, Volume 2013, Page 1
[15]
K. Chalvatzi, S. Spiroglou, A. Nikolaidou, and E. Diza
International Journal of Laboratory Hematology, 2013, Volume 35, Number 2, Page 193
[16]
Etienne Joosten, Pieter Lioen, Caroline Brusselmans, Christophe Indevuyst, and Nancy Boeckx
European Journal of Internal Medicine, 2013, Volume 24, Number 1, Page 63
[17]
E. Urrechaga, L. Borque, and J. F. Escanero
International Journal of Laboratory Hematology, 2013, Volume 35, Number 2, Page 144
[18]
Å. A. Sudmann, A. Piehler, and P. Urdal
International Journal of Laboratory Hematology, 2012, Volume 34, Number 6, Page 605
[19]
François Mullier, Elodie Lainey, Odile Fenneteau, Lydie Da Costa, Françoise Schillinger, Nicolas Bailly, Yvan Cornet, Christian Chatelain, Jean-Michel Dogne, and Bernard Chatelain
Annals of Hematology, 2011, Volume 90, Number 7, Page 759
[20]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
Journal of Clinical Laboratory Analysis, 2011, Volume 25, Number 3, Page 223
[21]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
Anemia, 2010, Volume 2010, Page 1
[22]
E. URRECHAGA, L. BORQUE, and J. F. ESCANERO
International Journal of Laboratory Hematology, 2011, Volume 33, Number 1, Page 30

Comments (0)

Please log in or register to comment.
Log in